跳至主要内容
临床试验/CTRI/2019/06/019648
CTRI/2019/06/019648招募中4 期

Evaluation of the utility of genotyping in patients with Budd Chiari Syndrome Versus Standard of care to assess impact on bleeding and costs - A randomized control trial.

Dr Akash Shukla0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients who are newly diagnosed for Budd Chiari and are warfarin naive
  • 2. Aged 18 years to 60 years of either gender
  • 3. Patients willing to give voluntarily written informed consent
  • 4. Patient willing to comply with protocol requirements

排除标准

  • 1.Genotype (CYP2C9 and VKORC1) known to participant from prior testing or available in medical record.
  • 2.Pregnancy or lactation
  • 3.Any other clinical condition as per physicianâ??s judgment which compromises safety of the participant or credibility of the data.
  • 4.Patients with contraindications to warfarin

研究者

发起方
Dr Akash Shukla

相似试验

Whether medical treatment based on genetic testing... | 临床试验